Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial

Sunil Bhandari^*, Samir Mehta, Natalie Rowland, Paul Cockwell

^*Corresponding author for this work

Birmingham Clinical Trials Unit

Research output: Contribution to journal › Letter › peer-review

1 results

Finished

STOP-ACEi - Multi-Centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACE-i)/Angiotensin Receptor Blocker (ARB) withdrawl in advanced renal disease
Rowland, N. (Principal Investigator)
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/14 → 31/12/21
Project: Other Government Departments